Alys E. Bradley

Suggest Changes

Writes About:

Learn More
Neuropathology analyses as end points during nonclinical efficacy and toxicity studies are challenging and require trained personnel and particular equipment to achieve optimal results. Accordingly,(More)
General session 4 of a 2010 scientific symposium sponsored jointly by the Society of Toxicologic Pathology and the International Federation of Societies of Toxicologic Pathologists considered the(More)